For each citation that was shared on social media (LinkedIn, Facebook, or Twitter) with the “@GenScript” tag, the author will be rewarded with a $10 Amazon gift card or 2,000 GS points.

Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles

Viruses. 2022-07; 
Shani Bekker, Henk Huismans, Vida van Staden
Products/Services Used Details Operation
Polyclonal Antibody Services … A primary antibody against AHSV VP3 was produced in rabbits by GenScript Biotech Corp (Piscataway, NJ, USA) (complete affinity-purified peptide polyclonal antibody) and diluted 1:… Get A Quote

Abstract

A unique characteristic of the African horse sickness virus (AHSV) major core protein VP7 is that it is highly insoluble, and spontaneously forms crystalline particles in AHSV-infected cells and when expressed in vitro. The aggregation of AHSV VP7 into these crystals presents many problems in AHSV vaccine development, and it is unclear whether VP7 aggregation affects AHSV assembly or contributes to AHSV pathogenesis. Here, we set out to abolish VP7 self-assembly by targeting candidate amino acid regions on the surface of the VP7 trimer via site-directed mutagenesis. It was found that the substitution of seven amino acids resulted in the complete disruption of AHSV VP7 self-assembly, which abolished the formatio... More

Keywords

African horse sickness virus, VP7, core-like particle, crystalline particle, equine, mutagenesis, solubility, vaccine, virus-like particle